Abdominal Fat Is Directly Associated With Inflammation In Persons With Type-2 Diabetes Regardless Of Glycemic Control - A Jordanian Study

被引:10
|
作者
Bawadi, Hiba [1 ]
Katkhouda, Rami [2 ]
Tayyem, Reema [3 ]
Kerkadi, Abdelhamid [1 ]
Raad, Samira Bou [4 ]
Subih, Hadil [2 ]
机构
[1] Qatar Univ, Coll Hlth Sci, Human Nutr Dept, QU Hlth, Bldg 106,Univ St,POB 2713, Doha, Qatar
[2] Jordan Univ Sci & Technol, Dept Nutr & Food Technol, Irbid, Jordan
[3] Univ Jordan, Dept Clin Nutr & Dietet, Amman, Jordan
[4] Amer Univ Sci & Technol, Dept Nutr & Food Sci, Beirut, Lebanon
来源
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY | 2019年 / 12卷
关键词
BMI; C-reactive protein; diabetes; IL-6; inflammation; obesity; C-REACTIVE PROTEIN; OXIDATIVE STRESS; BODY-FAT; INSULIN-RESISTANCE; TNF-ALPHA; MASS; ADIPOSITY; MELLITUS; OBESITY; HYPERGLYCEMIA;
D O I
10.2147/DMSO.S214426
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aim: Systemic inflammation is related to the progression of complications associated with diabetes. This study aimed to investigate the association between general and abdominal obesity and inflammation in patients with type-2 diabetes with or without glycemic control. Methods: A total of 198 men (n=73) and women (n=125) diagnosed with type 2 diabetes participated in this study. General obesity markers, body mass index (BMI), and abdominal fat were assessed. Circulating concentrations of glycated hemoglobin (HbA1C), C-reactive protein (CRP), and serum interleukin-6 (IL-6) were determined. Poor glycemic control and good glycemic control were defined as having fasting HbA1C concentrations >= 7% and <7%, respectively. Multivariate adjusted analysis of covariance was used to determine the relation between BMI and abdominal fat and markers of inflammation in patients with good and poor glycemic control. Results: Patients in <7% HbA1C category, those with high abdominal fat had approximate to 262% higher CRP and approximate to 30.6% higher IL-6 compared to those with low abdominal fat (p<0.05). Patients in >= 7% HbA1C category, those with high abdominal fat had approximate to 41.4% higher CRP and approximate to 33.9% higher IL-6 compared to those with low abdominal fat (p<0.05). Abdominal fat was directly related to CRP (p<0.023) and IL-6 (p<0.002) concentrations in both groups of type-2 diabetic patients with <7% and >= 7% HbA1C. In patients with >= 7% HbA1C, BMI was directly related to CRP (p<0.02) and IL-6 (p<0.047). Whereas in patients with <7% HbA1C, BMI was not associated with CRP or IL-6 concentrations. Conclusion: High level of abdominal fat is associated with systemic inflammation in type-2 diabetes regardless of glycemic control. Abdominal fat is a better predictor (determinant) of inflammation than BMI in patients with type-2 diabetes with or without glycemic control.
引用
收藏
页码:2411 / 2417
页数:7
相关论文
共 50 条
  • [1] Determination of risk factors associated with inflammation in hypertensive patients with type-2 diabetes mellitus in a Palestinian Diabetes Study
    Ellulu, Mohammed S.
    Naser, Ihab A.
    Abuhajar, Sahar M.
    Najim, Ahmed A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (09) : 1451 - 1459
  • [2] Impact of glycemic control on advanced glycation and inflammation in overweight and obese patients with type 2 diabetes mellitus
    Kalninova, J.
    Jakus, V
    Glejtkova, M.
    Kuracka, L.
    Sandorova, E.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2014, 115 (08): : 457 - 468
  • [3] Low-grade inflammation in persons with recently diagnosed type 2 diabetes: The role of abdominal adiposity and putative mediators
    Domazet, Sidsel L.
    Olesen, Thomas B.
    Stidsen, Jacob V.
    Svensson, Camilla K.
    Nielsen, Jens S.
    Thomsen, Reimar W.
    Jessen, Niels
    Vestergaard, Peter
    Andersen, Mette K.
    Hansen, Torben
    Brons, Charlotte
    Jensen, Verena H.
    Vaag, Allan A.
    Olsen, Michael H.
    Hojlund, Kurt
    DIABETES OBESITY & METABOLISM, 2024, 26 (06) : 2092 - 2101
  • [4] Glycemic control, inflammation, and cognitive function in older patients with type 2 diabetes
    Akrivos, Jimmy
    Ravona-Springer, Ramit
    Schmeidler, James
    LeRoith, Derek
    Heymann, Anthony
    Preiss, Rachel
    Hoffman, Hadas
    Koifman, Keren
    Silverman, Jeremy M.
    Beeri, Michal Schnaider
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2015, 30 (10) : 1093 - 1100
  • [5] Type-2 Diabetes and Kidney Stones: Impact of Diabetes Medications and Glycemic Control
    Torricelli, Fabio C. M.
    De, Shubha
    Gebreselassie, Surafel
    Li, Ina
    Sarkissian, Carl
    Monga, Manoj
    UROLOGY, 2014, 84 (03) : 544 - 548
  • [6] Is incident type 2 diabetes associated with cumulative excess weight and abdominal adiposity? Tehran Lipid and Glucose Study
    Zameni, Fatemeh
    Bakhtiyari, Mahmood
    Mansournia, Mohammad Ali
    Ramezankhani, Azra
    Azizi, Fereidoun
    Hadaegh, Farzad
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 136 : 134 - 142
  • [7] Improved Glycemic Control with Colesevelam Treatment in Patients with Type 2 Diabetes Is Not Directly Associated with Changes in Bile Acid Metabolism
    Brufau, Gemma
    Stellaard, Frans
    Prado, Kris
    Bloks, Vincent W.
    Jonkers, Elles
    Boverhof, Renze
    Kuipers, Folkert
    Murphy, Elizabeth J.
    HEPATOLOGY, 2010, 52 (04) : 1455 - 1464
  • [8] ASSOCIATION OF PANCREAS VOLUME AND INSULIN RESISTANCE WITH ABDOMINAL FAT DISTRIBUTION IN TYPE-2 DIABETES AS EVALUATED BY COMPUTED TOMOGRAPHY
    Oz, I. I.
    Bilici, M.
    Serifoglu, I.
    Arpaci, D. Karakaya
    Buyukuysal, M. C.
    Bayraktaroglu, T.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2017, 13 (02) : 168 - 173
  • [9] Ectopic fat in muscle and poor glycemic control are negatively associated with trabecular bone score in type 2 diabetes
    Araujo, Iana Mizumukai de
    Salmon, Carlos Ernesto Garrido
    Paula, Francisco Jose Albuquerque de
    CLINICS, 2024, 79
  • [10] Serum Chemerin Levels Are Associated with Abdominal Visceral Fat in Type 2 Diabetes
    Han, Juyoung
    Kim, So Hun
    Suh, Young Ju
    Lim, Hyun Ae
    Shin, Heekyoung
    Cho, Soon Gu
    Kim, Chei Won
    Lee, Seung Youn
    Lee, Dae Hyung
    Hong, Seongbin
    Kim, Yong Seong
    Nam, Moon-Suk
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2016, 31 (06) : 924 - 931